Evidence map›Paper›PMID 42701971›Full record

ArticleAbdominal radiology (New York)2026

Safety and efficacy of magnetic resonance-guided high-intensity focused ultrasound surgery (MRgFUS) in adenomyosis with dysmenorrhea.

Qi Zhang, Haicheng Li, Haoxiong Li, Linghui Xu, Yujia Shen, Wai Yan Ryana Fok, Mao Lai, Xiongrui Guo, Yiting Wang, Jamie Jiangmin Hou and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qi Zhang *Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-9271-223X
Haicheng Li *Jiangmen School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China.
Haoxiong Li *Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Linghui XuDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Yujia ShenDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Wai Yan Ryana FokOxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID http://orcid.org/0009-0007-5067-8302
Mao LaiDepartment of Radiology, The First People's Hospital of Jinghong, Yunnan, China.
Xiongrui GuoDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Yiting WangDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Jamie Jiangmin HouDepartment of Medicine and NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-5836-1827
Woo Yuan XinDepartment of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
Junhai Zhang *Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China. jhzhang007@fudan.edu.cn.ORCID http://orcid.org/0000-0002-3514-0471
Xiaohong Ruan *Jiangmen School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China. ruanxiaohong@jmszxyy.com.cn.

Funding

Shanghai Municipal Health Commission Grant No.20224Y0382
6 · The paper itself

Abstract

purposeTo evaluate the safety and short-term efficacy of magnetic resonance-guided high-intensity focused ultrasound surgery (MRgFUS) for adenomyosis-associated dysmenorrhea. MATERIALS AND

methodsThis retrospective single-center cohort included 62 patients with MRI-confirmed adenomyosis and dysmenorrhea who underwent MRgFUS between October 2018 and March 2021. Uterine volume, adenomyosis lesion volume, and non-perfused volume (NPV) were measured on MRI. The non-perfused volume ratio (NPVR) was calculated as NPV divided by lesion volume. Dysmenorrhea severity was assessed using the visual analogue scale (VAS). Follow-up data were analyzed as available cases at 3, 6, and 12 months.

resultsAll 62 patients completed MRgFUS. The mean immediate NPVR was 69.12% ± 17.64%. MRI follow-up was available in 53/62 patients (85.5%) at 3 months, 38/62 (61.3%) at 6 months, and 13/62 (21.0%) at 12 months. Mean uterine volume decreased from 201.38 ± 126.17 cm

conclusionMRgFUS was technically feasible and appeared safe in this retrospective cohort, with encouraging short-term improvement in dysmenorrhea and early reduction in adenomyosis lesion volume. Because 12-month follow-up was available for only 21.0% of patients and no control group was included, long-term efficacy should be interpreted cautiously and confirmed in prospective controlled studies.

Indexed as

AdenomyosisDysmenorrheaMagnetic resonance imagingSafetyUltrasonic therapy

Identifiers

PMID42701971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.